Restrictive versus liberal transfusion strategy for red blood cell transfusion in critically ill patients and in patients with acute coronary syndrome: A systematic review, meta-analysis and trial sequential analysis

Minerva Anestesiologica

Volumn 82, Issue 5, 2016, Pages 582-598

  Melchor, Javier Ripollés ^a   Francés, Rubén Casans ^b   Espinosa, Ángel ^c   Hurtado, Eugenio Martartínez ^a   Pérez, Rosalía Navarro ^a   Gurumeta, Alfredo Abad ^d   Basora, Misericordia ^e   Calvovecino, José M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c ÖREBRO UNIVERSITY   (Sweden)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

Anemia; Critical illness; Hemoglobins; Meta analysis

Indexed keywords

HEMOGLOBIN;

ACUTE HEART INFARCTION; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; CRITICALLY ILL PATIENT; ERYTHROCYTE TRANSFUSION; HEART MUSCLE ISCHEMIA; HUMAN; LIBERAL ERYTHROCYTE TRANSFUSION; LUNG EDEMA; META ANALYSIS; MORTALITY; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTRICTIVE ERYTHROCYTE TRANSFUSION; REVIEW; SENSITIVITY ANALYSIS; SEQUENTIAL ANALYSIS; SYSTEMATIC REVIEW; ACUTE CORONARY SYNDROME; ANEMIA; CRITICAL ILLNESS;

ACUTE CORONARY SYNDROME; ANEMIA; CRITICAL ILLNESS; ERYTHROCYTE TRANSFUSION; HEMOGLOBINS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84971350153     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968;405:5-37.
2. Vincent J-L, Baron J-F, Reinhart K, Gattinoni L, Thijs L, Webb A, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002;288:1499-507.
3. Corwin HL, Gettinger A, Pearl RG, Fink MP, Levy MM, Abraham E, et al. The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004;32:39-52.
4. Westbrook A, Pettila V, Nichol A, Bailey MJ, Syres G, Murray L, et al. Transfusion practice and guidelines in Australian and New Zealand intensive care units. Intensive Care Med 2010;36:1138-46.
5. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, et al. Thrombolysis in Myocardial Infarction (TI MI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987;76:142-54.
6. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001;345:1230-6.
7. Fortune JB, Feustel PJ, Saifi J, Stratton HH, Newell JC, Shah DM. Influence of hematocrit on cardiopulmonary function after acute hemorrhage. J Trauma 1987;27:243-9.
8. Casutt M, Seifert B, Pasch T, Schmid ER, Turina MI, Spahn DR. Factors influencing the individual effects of blood transfusions on oxygen delivery and oxygen consumption. Crit Care Med 1999;27:2194-200.
9. Parsons EC, Hough CL, Seymour CW, Cooke CR, Rubenfeld GD, Watkins TR. Red blood cell transfusion and outcomes in patients with acute lung injury, sepsis and shock. Crit Care 2011;15:R221.
10. Vincent J-L, Sakr Y, Sprung C, Harboe S, Damas P. Are blood transfusions associated with greater mortality rates? Results of the Sepsis Occurrence in Acutely Ill Patients study. Anesthesiology 2008;108:31-9.
11. Sakr Y, Lobo S, Knuepfer S, Esser E, Bauer M, Settmacher U, et al. Anemia and blood transfusion in a surgical intensive care unit. Crit Care 2010;14:R92.
12. Leal-Noval SR, Munoz-Gomez M, Jimenez-Sanchez M, Cayuela A, Leal-Romero M, Puppo-Moreno A, et al. Red blood cell transfusion in non-bleeding critically ill patients with moderate anemia: is there a benefit? Intensive Care Med 2013;39:445-53.
13. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004;292:1555-62.
14. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008;36:2667-74.
15. Rosland RG, Hagen MU, Haase N, Holst LB, Plambech M, Madsen KR, et al. Red blood cell transfusion in septic shock-clinical characteristics and outcome of unselected patients in a prospective, multicentre cohort. Scand J Trauma Resusc Emerg Med 2014;22:14.
16. Park DW, Chun B-C, Kwon S-S, Yoon YK, Choi WS, Sohn JW, et al. Red blood cell transfusions are associated with lower mortality in patients with severe sepsis and septic shock: a propensity-matched analysis. Crit Care Med 2012;40:3140-5.
17. Cortes Buelvas A. Anemia and transfusion of red blood cells. Colomb Med (Cali) 2013;44:236-42.
18. Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409-17.
19. Carson JL, Hill S, Carless P, Hebert P, Henry D. Transfusion triggers: a systematic review of the literature. Transfus Med Rev 2002;16:187-99.
20. Salpeter SR, Buckley JS, Chatterjee S. Impact of more restrictive blood transfusion strategies on clinical outcomes: a meta-analysis and systematic review. Am J Med 2014;127:124-131.e3.
21. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012;4:CD002042.
22. Hebert PC, Tinmouth A, Corwin HL. Controversies in RBC transfusion in the critically ill. Chest 2007;131:1583-90.
23. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRIS MA statement. Ann Intern Med 2009;151:264-9-W64.
24. JPT H, editors GS. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011Available from www.cochrane-handbook.org.
25. Jakobsen JC, Wetterslev J, Winkel P, Lange T, Gluud C. Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods. BMC Med Res Methodol 2014;14:120.
26. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
27. Jammer I, Wickboldt N, Sander M, Smith A, Schultz MJ, Pelosi P, et al. Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: A statement from the ESA-ESICM joint taskforce on perioperative outcome measures; 2014 [Internet]. Available from: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id= 25058504&retmode=ref&cmd=prlinks [cited Apr 1, 2016].
28. Review Manager (RevMan) [Computer program]. Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
29. Wallace BC, Dahabreh IJ, Trikalinos TATA, Lau J, Trow P, Schmid CH: Closing the gap between methodologists and end-users: R as a computational back-end. J Stat Softw 2012, 49:5.
30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
31. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
32. Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004;23:1351-75.
33. Strassburger K, Bretz F. Compatible simultaneous lower confidence bounds for the Holm procedure and other Bonferroni-based closed tests. Stat Med 2008;27:4914-27.
34. Thorlund K, Imberger G, Walsh M, Chu R, Gluud C, Wetterslev J, et al. The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis-a simulation study. PLoS One 2011;6:e25491.
35. Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol 2008;61:763-9.
36. Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User Manual for Trial Sequential Analysis (TSA). Copenhagen, Denmark: Copenhagen Trial Unit, Centre for Clinical Intervention Research 2011;1-115.
37. Neumann I, Pantoja T, Penaloza B, Cifuentes L, Rada G. [The GRA DE system: a change in the way of assessing the quality of evidence and the strength of recommendations]. Rev Med Chil 2014;142:630-5.
38. Jakobsen JC, Gluud C, Winkel P, Lange T, Wetterslev J. The thresholds for statistical and clinical significance-a five-step procedure for evaluation of intervention effects in randomised clinical trials. BMC Med Res Methodol 2014;14:34.
39. Hebert PC, Wells G, Marshall J, Martin C, Tweeddale M, Pagliarello G, et al. Transfusion requirements in critical care. A pilot study. Canadian Critical Care Trials Group. JAMA 1995;273:1439-44.
40. Cooper HA, Rao SV, Greenberg MD, Rumsey MP, McKenzie M, Alcorn KW, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol 2011;108:1108-11.
41. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011;365:2453-62.
42. Walsh TS, Boyd JA, Watson D, Hope D, Lewis S, Krishan A, et al. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial. Crit Care Med 2013;41:2354-63.
43. Holst LB, Haase N, Wetterslev J, Wernerman J, Guttormsen AB, Karlsson S, et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 2014;371:1381-91.
44. Hebert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Crit Care Med 2001;29:227-34.
45. Hogshire L, Carson JL. Red blood cell transfusion: what is the evidence when to transfuse? Curr Opin Hematol 2013;20:546-51.
46. Fernandes CJJ, Akamine N, De Marco FV, De Souza JA, Lagudis S, Knobel E. Red blood cell transfusion does not increase oxygen consumption in critically ill septic patients. Crit Care 2001;5:362-7.
47. Hebert PC, Carson JL. Transfusion threshold of 7 g per deciliter-the new normal. N Engl J Med 2014;371:1459-61.
48. Chatterjee S, Wetterslev J, Sharma A, Lichstein E, Mukherjee D. Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis. JAMA Intern Med 2013;173:132-9.
49. Jan KM, Heldman J, Chien S. Coronary hemodynamics and oxygen utilization after hematocrit variations in hemorrhage. Am J Physiol 1980;239:H326-32.
50. Mirski MA, Frank SM, Kor DJ, Vincent J-L, Holmes DRJ. Restrictive and liberal red cell transfusion strategies in adult patients: reconciling clinical data with best practice. Crit Care 2015;19:202.
51. Wilkerson DK, Rosen AL, Sehgal LR, Gould SA, Sehgal HL, Moss GS. Limits of cardiac compensation in anemic baboons. Surgery 1988;103:665-70.
52. Levy PS, Kim SJ, Eckel PK, Chavez R, Ismail EF, Gould SA, et al. Limit to cardiac compensation during acute isovolemic hemodilution: influence of coronary stenosis. Am J Physiol 1993;265:H340-9.
53. Sabatine MS, Morrow DA, Giugliano RP, Burton PBJ, Murphy SA, McCabe CH, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005;111:2042-9.
54. Lawler PR, Filion KB, Dourian T, Atallah R, Garfinkle M, Eisenberg MJ. Anemia and mortality in acute coronary syndromes: a systematic review and meta-analysis. Am Heart J 2013;165:143-5.
55. Hebert PC, Hu LQ, Biro GP. Review of physiologic mechanisms in response to anemia. CMAJ 1997;156:S27-S40.
56. Tsai AG, Cabrales P, Intaglietta M. Microvascular perfusion upon exchange transfusion with stored red blood cells in normovolemic anemic conditions. Transfusion 2004;44:1626-34.
57. Murphy GJ, Pike K, Rogers CA, Wordsworth S, Stokes EA, Angelini GD, et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 2015;372:997-1008.
58. Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, Pike F, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014;370:1683-93.
59. Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014;371:1496-506.
60. Varney SJ, Guest JF. The annual cost of blood transfusions in the UK. Transfus Med 2003;13:205-18.
61. Vallet B, Adamczyk S, Barreau O, Lebuffe G. Physiologic transfusion triggers. Best Pract Res Clin Anaesthesiol 2007;21:173-81.
62. Vincent J-L. Indications for blood transfusions: too complex to base on a single number? Ann Intern Med 2012;157:71-2.
63. Hare GMT, Tsui AKY, Ozawa S, Shander A. Anaemia: can we define haemoglobin thresholds for impaired oxygen homeostasis and suggest new strategies for treatment? Best Pract Res Clin Anaesthesiol 2013;27:85-98.
64. Hare GMT, Tsui AKY, Crawford JH, Patel RP. Is methemoglobin an inert bystander, biomarker or a mediator of oxidative stress-The example of anemia? Redox Biol 2013;1:65-9.
65. Hare GMT, Mu A, Romaschin A, Tsui AKY, Shehata N, Beattie WS, et al. Plasma methemoglobin as a potential biomarker of anemic stress in humans. Can J Anaesth 2012;59:348-56.